<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166310">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01674998</url>
  </required_header>
  <id_info>
    <org_study_id>11-DAT-013</org_study_id>
    <nct_id>NCT01674998</nct_id>
  </id_info>
  <brief_title>Understanding the Natural History of REM Sleep Behavior Disorder</brief_title>
  <official_title>Understanding Autonomic Function in REM Sleep Behavior Disorder, Parkinsonism and Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Parkinson's Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Parkinson's Institute</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to determine if safe, simple and non-invasive tests
      such as an electrocardiogram (EKG), a smell test, or a blood test could be used to identify
      neurological disorders before typical symptoms occur.  Researchers believe that early
      identification of these disorders could lead to treatments to prevent, delay, or slow the
      development of one of more of these diseases. Some people with REM sleep behavior disorder
      (RBD) may go on to develop Parkinson's disease or another related neurological disorder, but
      many do not.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>REM Sleep Behavior Disorder</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and/or saliva DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Sleep disorders clinics Neurology practices Medical practices Sleep disorders support
        groups Web-based advertisements Community outreach
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic REM sleep behavior

        Exclusion Criteria:

          -  Parkinson's disease

          -  Alzheimer's disease

          -  Multiple system atrophy

          -  Dementia

          -  Minors
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Parkinson's Institute</name>
      <address>
        <city>Sunnyvale</city>
        <state>California</state>
        <zip>94085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sak Sundarrajan</last_name>
      <phone>800-786-2958</phone>
      <phone_ext>434</phone_ext>
      <email>sleepstudy@thepi.org</email>
    </contact>
    <contact_backup>
      <last_name>Kathleen Comyns, MPH</last_name>
      <phone>800-786-2958</phone>
      <phone_ext>434</phone_ext>
      <email>sleepstudy@thepi.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 27, 2012</lastchanged_date>
  <firstreceived_date>August 27, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Parkinson's Institute</investigator_affiliation>
    <investigator_full_name>J. William Langston</investigator_full_name>
    <investigator_title>Founder and CEO</investigator_title>
  </responsible_party>
  <keyword>REM Sleep Behavior Disorder</keyword>
  <keyword>RBD</keyword>
  <keyword>Dream</keyword>
  <keyword>Dreams</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>REM Sleep Behavior Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
